Skip to main content

FluLaval News (Page 2)

In Good News for U.S., Flu Vaccine Working Well in South America

MONDAY, Sept. 11, 2023 – In a finding that should ease the minds of Americans ahead of another flu season, this year's vaccines have already cut the risk of hospitalization in half during the South A...

Recommendations Updated for Flu Vaccine in Children

TUESDAY, Aug. 29, 2023 – Recommendations have been updated for influenza vaccination among U.S. children for the 2023 to 2024 season, according to a policy statement and accompanying technical...

Vaccines Against Shingles, Pneumonia May Also Lower Your Alzheimer's Risk

MONDAY, Aug. 21, 2023 – Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals. Prior vaccination with the shingles...

Gene Changes Made This Season's Bird Flu More Severe

FRIDAY, June 2, 2023 – Genetic mutations caused this latest bird flu season to become more severe, increasing the risk it poses to humans and other mammals, a new study finds. The H5N1 avian...

CureVac’s Coronavirus Vaccine at the Center of a Fight for Control

CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...

GSK Receives FDA Approval for Expanded Indication for FluLaval Quadrivalent (Influenza Vaccine) for Infants 6 Months and Older

18 November 2016 – GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research expanding the indication ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Influenza Prophylaxis

FluLaval patient information at Drugs.com